IPO Direct Listing vs. Traditional: Pros and Cons for Going Public

Traditional IPO’s and direct listings allow companies to go public and sell shares. But what are the benefits? How do they work?

Volta IPO: Stock Coming in 2021 With SPAC Tortoise Acquisition II

Volta stock is official. The company announced an agreement with SPAC Tortoise Acquisition II Corp. (NYSE: SNPR) for a Volta IPO in 2021. Should you invest?

SoFi IPO: Stock Coming in 2021 via Palihapitiya’s Newest SPAC

A SoFi IPO was confirmed when the company put out a press release Thursday. Investors can expect SoFi stock via SPAC IPO in 2021. But should you invest?

Unqork IPO: Will This No-Code Platform Company Be a 2021 Unicorn?

Unqork IPO rumors increased after the company closed its Series C funding. Unqork stock value went up, and investors want to know if this is a 2021 unicorn.

HydraFacial IPO: Stock Coming via Former Allergan CEO’s SPAC

The HydraFacial IPO is expected in early 2021. It values the company at $1.1 billion and will bring HydraFacial stock to market. But should you invest?

Affirm IPO: Date, Price and More for AFRM Stock

The Affirm IPO is filed with the SEC. That means the e-commerce platform is going public. But should you invest in Affirm stock? Here’s what we know.

Telos IPO Bringing Stock to Nasdaq in $210 Million Deal

The Telos IPO is just around the corner. But some investors aren’t so sure about Telos stock. Should you invest in this opportunity? Here’s what we know…

Compass Therapeutics IPO Set for $50 Million Nasdaq Offering

The Compass Therapeutics IPO is set to raise $50 million on November 13. But is Compass Therapeutics stock a good investment opportunity?